Stockholders approve charter amendments for officer exculpation and forum selection removal at annual meeting

Amphastar Pharmaceuticals, Inc.

Elected three Class III directors: Jack Y. Zhang, Richard Prins, Diane G. Gerst (each with majority support).
Approved charter amendment for officer exculpation under Delaware law (35.5M for, 2.9M against).
Approved removal of forum selection provision from charter (37.4M for, 52k against).
Ratified Ernst & Young as independent auditor for fiscal 2025 (41.5M for).
Bylaws amended to specify Delaware Court of Chancery as exclusive forum for certain internal actions.

item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.